Influence of gene polymorphisms of the renin-angiotensin system on clinical outcome in heart failure among the Chinese

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 653-657

  Sanderson, J E ^a   Yu, C M ^a   Young, R P ^a   Shum, I O L ^a   Wei, S ^a   Arumanayagam, M ^a   Woo, K S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ATRIAL NATRIURETIC FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELISM; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CHINA; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENOTYPE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURVIVAL;

EID: 0032913094     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70218-8     Document Type: Article

References (20)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
2. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.
3. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
4. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
5. Lindpaintner K, Pfeifer MA, Kreutz R, Stampfer MJ Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
6. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA, Jensen G, Tybjaerg-Hansen A. ACE Gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. Circulation 1997;95:2358-67.
7. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-5.
8. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995;25:1627-31.
9. Sanderson JE, Young RP, Yu CM, Chan S, Critchley JAJH, Woo KS. Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilated cardiomyopathy in the Chinese. Am J Cardiol 1996;77:1008-10.
10. Andersson B, Sylvan C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996;28:162-7.
11. Young RP, Sanderson JE, Tomlinson B, Woo KS, Critchley JAJH. Angiotensin converting enzyme insertion-deletion polymorphism in the Chinese. J Hypertension 1995;13:1479-83.
12. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, Ogihara T. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994;8:521-4.
13. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charm A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-9.
14. Benetos A, Topouchian J, Richard S, Gautier S, Bonnardeaux A, Asmar R, et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995;26:44-7.
15. Tiret L, Bonnardeaux A, Poirer O, Ricard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-3.
16. Young RP, Chan JCN, Poon E, Critchley JAJH, Nicholls G, Cockram CS. Associations between albuminuria and angiotensinogen T235 and angiotensin converting enzyme deletion polymorphisms in Chinese NIDDM patients. Diabetes Care 1998;21:431-7.
17. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, et al. Hypertension, serum angiotensinogen and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997;95:2348-50.
18. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.
19. Yu CM, Sanderson JE, Chan S, Yeung L, Hung YT, Woo KS. Right ventficular diastolic dysfunction in heart failure. Circulation 1996;93:1509-14.
20. Weber KT, Sun Y, Tyagi SC, Cleutjens JPM. Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994;26:279-92.